Testing effectiveness (Phase 2)Study completedNCT01342796
What this trial is testing
Humoral and Cell Mediated Immunity and Safety of MF59C.1-adjuvanted Subunit Influenza Vaccine or a Conventional Subunit Influenza Vaccine in Previously Unvaccinated Healthy Subjects
Who this might be right for
Seasonal InfluenzaInfluenzaInfluenza Due to Unspecified Influenza Virus+1 more
Novartis Vaccines 84